VedaBio
PrivateLast Round
Series A
Extension
Sep 23, 2025
Total Funding Raised
$40.13M
Company Overview
VedaBio is a biotechnology company that develops molecular diagnostics equipment using a CRISPR-based platform for rapid, amplification-free detection of multiple analytes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VedaBio Comparables
Compare VedaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IntelliGenome | 83% | |
| GRIP Molecular Technologies | 79% | |
| OraSure Technologies Inc | 78% |
VedaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 23, 2025 | ||||
| Series A | Oct 17, 2023 |
Key People
Founding team and executive leadership
VedaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OMX Ventures | Series A, Series A Extension |
| Kleinmuntz Associates | Series A, Series A Extension |
| Y Combinator | Accelerator |
| OMX Ventures | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2025
$40M round completed.
- Sep 23, 2025
Signed a strategic agreement with Siemens Healthineers.
Recent news
Latest coverage and updates
- hiresSep 25, 2026
VedaBio, Inc. hired Valerie Dixon on Sep 17th '26.
VedaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VedaBio's valuation, stock price, and market status.
Is VedaBio a public or private company?
VedaBio is a private company.
What is the current stock price of VedaBio?
VedaBio is a private company with no public stock price. No recent secondary market data is available.
How much is VedaBio worth (valuation)?
Valuation information for VedaBio is not publicly available.
Can I buy VedaBio stock?
VedaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VedaBio's last funding round?
VedaBio's most recent funding round was Series A on September 23, 2025.
Who are the main investors in VedaBio?
Key investors in VedaBio include OMX Ventures.
Will VedaBio IPO soon?
No public IPO plans have been announced for VedaBio.
How can I track VedaBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VedaBio's secondary market activity and sign up for updates.